Scott M Dehm

34PUBLICATIONS
301CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 18, 2026
Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.

|Jun 17, 2026
3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer.

|Mar 20, 2026
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling.

Yongyong Yang, Ting-You Wang, Joshua Fry

|Jan 26, 2026
Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial.

José C Valentín López, Chenxi Yu, Todd P Knutson

|Jul 25, 2025
Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin-driven Tumor Progression and Immune Escape in Prostate Cancer.

Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li

|Feb 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic Essentiality.

Ali T Arafa, Siddhartha Yadav, Catherine H Marshall

Pageof 6

Frequent Collaborators

6 joint publications

Joshua M Lang

6 joint publications

Emmanuel S Antonarakis

5 joint publications

Samuel P Pitzen

5 joint publications

Elisabeth I Heath